Jessica J. Kandel to Neovascularization, Pathologic
This is a "connection" page, showing publications Jessica J. Kandel has written about Neovascularization, Pathologic.
Connection Strength
2.977
-
Notch: a key regulator of tumor angiogenesis and metastasis. Histol Histopathol. 2012 02; 27(2):151-6.
Score: 0.353
-
Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade. Int J Oncol. 2009 Jan; 34(1):79-87.
Score: 0.285
-
Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature. Int J Oncol. 2004 Sep; 25(3):549-53.
Score: 0.211
-
Antiangiogenic therapy for the treatment of pediatric solid malignancies. Semin Pediatr Surg. 2004 Feb; 13(1):53-60.
Score: 0.203
-
Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis. Mol Cancer Res. 2004 Jan; 2(1):36-42.
Score: 0.202
-
Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor. J Pediatr Surg. 2003 Nov; 38(11):1569-73.
Score: 0.199
-
p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease. J Pediatr Surg. 2002 Mar; 37(3):523-7.
Score: 0.178
-
Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor. J Pediatr Surg. 2001 Aug; 36(8):1177-81.
Score: 0.171
-
Pathological angiogenesis in a murine model of human Wilms' tumor. J Pediatr Surg. 1999 May; 34(5):676-9.
Score: 0.146
-
Notch suppresses angiogenesis and progression of hepatic metastases. Cancer Res. 2015 Apr 15; 75(8):1592-602.
Score: 0.109
-
Evaluating tumor angiogenesis. Methods Mol Biol. 2013; 980:341-51.
Score: 0.094
-
Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy. Ultrasound Med Biol. 2012 Jun; 38(6):1019-29.
Score: 0.089
-
Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell. 1991 Sep 20; 66(6):1095-104.
Score: 0.086
-
Vascular characterization of clear cell sarcoma of the kidney in a child: a case report and review. J Pediatr Surg. 2009 Oct; 44(10):2031-6.
Score: 0.075
-
Vascular endothelial growth factor blockade rapidly elicits alternative proangiogenic pathways in neuroblastoma. Int J Oncol. 2009 Feb; 34(2):401-7.
Score: 0.072
-
A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Cancer Res. 2008 Jun 15; 68(12):4727-35.
Score: 0.069
-
Vascular remodeling and clinical resistance to antiangiogenic cancer therapy. Drug Resist Updat. 2004 Aug-Oct; 7(4-5):289-300.
Score: 0.053
-
Blockade of her2/neu decreases VEGF expression but does not alter HIF-1 distribution in experimental Wilms tumor. Oncol Rep. 2003 Sep-Oct; 10(5):1271-4.
Score: 0.049
-
Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proc Natl Acad Sci U S A. 2003 Jun 24; 100(13):7785-90.
Score: 0.049
-
Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis. J Pediatr Surg. 2003 Mar; 38(3):308-14; discussion 308-14.
Score: 0.048
-
Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor. J Pediatr Surg. 2001 Dec; 36(12):1781-4.
Score: 0.044
-
All angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor. J Pediatr Surg. 2001 Feb; 36(2):287-90.
Score: 0.041
-
Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumor. J Pediatr Surg. 1999 May; 34(5):743-7; discussion 747-8.
Score: 0.036
-
Inter-rater reliability of surgical reviews for AREN03B2: a COG renal tumor committee study. J Pediatr Surg. 2014 Jan; 49(1):154-8; discussion 158.
Score: 0.025
-
Monitoring early tumor response to drug therapy with diffuse optical tomography. J Biomed Opt. 2012 Jan; 17(1):016014.
Score: 0.022
-
Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation. Mol Cancer Res. 2008 Jan; 6(1):1-9.
Score: 0.017
-
Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling. Cancer Res. 2006 Apr 15; 66(8):4378-84.
Score: 0.015
-
TNP-470 promotes initial vascular sprouting in xenograft tumors. Mol Cancer Ther. 2004 Mar; 3(3):335-43.
Score: 0.013
-
Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma. Int J Oncol. 2003 Dec; 23(6):1651-5.
Score: 0.013
-
Topotecan is anti-angiogenic in experimental hepatoblastoma. J Pediatr Surg. 2002 Jun; 37(6):857-61.
Score: 0.011